Pengcheng Wang
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum to "Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism" [Acta Pharm Sin B 14 (2024) 4883-4898].
Journal: Acta pharmaceutica Sinica. B
Published: May 15, 2025
Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism.
Journal: Acta pharmaceutica Sinica. B
Published: February 07, 2024
The Hydrophilic Metabolite UMP Alleviates Obesity Traits through a HIF2α-ACER2-Ceramide Signaling Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 06, 2023
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine.
Journal: Nature
Published: July 16, 2021
Macrophage HIF-2α suppresses NLRP3 inflammasome activation and alleviates insulin resistance.
Journal: Cell reports
Published: May 05, 2021
Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.
Journal: The Journal of clinical investigation
Published: August 03, 2020
Adipocyte-derived Lysophosphatidylcholine Activates Adipocyte and Adipose Tissue Macrophage Nod-Like Receptor Protein 3 Inflammasomes Mediating Homocysteine-Induced Insulin Resistance.
Journal: EBioMedicine
Published: March 09, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026